Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Translucent AI Raises $27M Series A Led by GV
Translucent Brings its AI Platform to Health Systems Across the Country, like Duly Health and Care, Wray Hospital and Clinic, and Springfield Clinic, to Give Leaders Early Visibility into Financial Risk and a Clear Path to Respond
Translucent, the AI platform for healthcare finance, today announced a $27 million Series A funding round led by GV (Google Ventures), with continued participation from NEA, Virtue, and FPV Ventures. The preemptive, oversubscribed round comes just months after the company’s $7 million seed round, announced in August 2025, reflecting the urgent need for real-time financial visibility in an industry facing unprecedented fiscal pressure.
“We see Translucent as an important tool that has the potential to help us improve the scale and visibility needed to better understand where revenue and operational opportunities exist,” said John Orsini, CFO at Northwestern Medicine.
Healthcare spending was projected to reach $5.6 trillion by the end of 2025, a 7.1% increase from the year prior, and early signs indicate that costs will only continue to rise in 2026. However, that growth isn’t translating into sustainable margins. Healthcare finance has crossed a threshold where the volume and complexity of data across siloed areas like labor, supplies, claims, contract economics, equipment, and other cost centers make real-time, manual reconciliation impractical, forcing human teams to manage the business in hindsight. Without real-time visibility, organizations can’t identify where revenue is leaking or take action fast enough to make meaningful changes. This lack of financial visibility contributed to 20 hospital bankruptcies and 23 hospital and emergency department closures last year. Currently, more than 700 rural hospitals are at risk of closure, displacing patients and making access to care even more challenging.
“Healthcare organizations are in trouble, and the financial infrastructure that should help leaders respond is fundamentally broken. That’s why healthcare needs a true financial operating system built for this moment,” said Jack O’Hara, Founder and CEO at Translucent. “We built Translucent to give hospitals and clinics what they desperately need: real-time clarity and control, so they can catch problems early enough to act and keep their doors open for the patients who need them.”
Translucent is the first agentic AI platform for healthcare finance. It consolidates operational, clinical, and financial data into a unified view, continuously monitoring signals across the organization to surface real-time financial insights and identify root causes the moment they emerge. Translucent replaces the patchwork of disparate tools, spreadsheets, and manual operations that have historically defined healthcare financial operations, giving teams a shared source of up-to-date truth. Rather than waiting for month-end close or pulling static reports…
Full release here, originally announced March 11th, 2026.
HEARTio Announces Closing of $4.25 Million Financing for its AI Algorithm to Detect Warning Signs of Heart Attacks
Heart Input Output Inc. (HEARTio), an artificial intelligence healthcare diagnostics company, today announced the closing of $4.25 Million in new seed financing with participation from Intelligence Ventures, Audacious Capital, VU Venture Partners, LifeX (Pittsburgh), Bessel, and others. These funds will enable the launch of HEARTio’s pivotal study seeking FDA clearance for HEARTio’s flagship product, ECGio.
“This successful round of financing is a testament to the momentum we are building in bringing ECGio to market,” said Utkars Jain, Co-Founder and CEO at HEARTio. “Up and down the cap table, we have so many people that believe in us from all around the world — executives, physicians, venture capitalists, and family offices. With this financing, we expect to complete our pivotal study and submit the technology to the FDA for clearance. Our technology has the potential to democratize cardiovascular care and help create a world where no one experiences a heart attack.”
“In addition to our investors, we have been incredibly lucky to work with so many globally renowned experts in Cardiology, Emergency Medicine, Cardiothoracic Surgery, Medical Devices, Biostats, Life Science Tools, and more,” said Adam Butchy, Co-Founder of HEARTio. “This amazing team has allowed us to stay focused on patient care and technological innovation, making sure that we are creating something that is truly disruptive and impactful.”
HEARTio is a digital diagnostics company using AI to detect coronary artery disease (CAD), more quickly, more accurately, and at a lower cost as compared to the current standard of care…
Full release here, originally announced March 16th, 2026.
No comments:
Post a Comment